rs11999

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001680.5(FXYD2):​c.*176T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 167,860 control chromosomes in the GnomAD database, including 7,538 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6588 hom., cov: 32)
Exomes 𝑓: 0.33 ( 950 hom. )

Consequence

FXYD2
NM_001680.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.289

Publications

7 publications found
Variant links:
Genes affected
FXYD2 (HGNC:4026): (FXYD domain containing ion transport regulator 2) This gene encodes a member of the FXYD family of transmembrane proteins. This particular protein encodes the sodium/potassium-transporting ATPase subunit gamma. Mutations in this gene have been associated with Renal Hypomagnesemia-2. Alternatively spliced transcript variants have been described. Read-through transcripts have been observed between this locus and the upstream FXYD domain-containing ion transport regulator 6 (FXYD6, GeneID 53826) locus.[provided by RefSeq, Feb 2011]
FXYD6-FXYD2 (HGNC:39978): (FXYD6-FXYD2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring FXYD domain-containing ion transport regulator 6 (GeneID 53826) and sodium/potassium-transporting ATPase subunit gamma (GeneID 486) genes on chromosome 11. One read-through transcript produces a fusion protein that shares sequence identity with each individual gene product, while another read-through transcript encodes a protein that has a distinct C-terminus and only shares sequence identity with the upstream locus (GeneID 53826). [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-117820203-A-C is Benign according to our data. Variant chr11-117820203-A-C is described in ClinVar as Benign. ClinVar VariationId is 302515.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.354 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FXYD2NM_001680.5 linkc.*176T>G 3_prime_UTR_variant Exon 6 of 6 ENST00000292079.7 NP_001671.2 P54710-1
FXYD6-FXYD2NM_001204268.3 linkc.*176T>G 3_prime_UTR_variant Exon 11 of 11 NP_001191197.1 A0A087WZ82
FXYD6-FXYD2NM_001243598.4 linkc.*210T>G 3_prime_UTR_variant Exon 10 of 10 NP_001230527.1 A0A0A6YYL5
FXYD2NM_021603.4 linkc.*176T>G 3_prime_UTR_variant Exon 6 of 6 NP_067614.1 P54710-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FXYD2ENST00000292079.7 linkc.*176T>G 3_prime_UTR_variant Exon 6 of 6 1 NM_001680.5 ENSP00000292079.2 P54710-1
FXYD6-FXYD2ENST00000614497.5 linkc.*176T>G downstream_gene_variant 3 ENSP00000482442.1 A0A087WZ82

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
41931
AN:
151986
Hom.:
6588
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.150
Gnomad AMI
AF:
0.293
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.333
Gnomad EAS
AF:
0.0955
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.357
Gnomad OTH
AF:
0.279
GnomAD4 exome
AF:
0.329
AC:
5183
AN:
15756
Hom.:
950
Cov.:
0
AF XY:
0.327
AC XY:
2617
AN XY:
8014
show subpopulations
African (AFR)
AF:
0.148
AC:
86
AN:
582
American (AMR)
AF:
0.380
AC:
392
AN:
1032
Ashkenazi Jewish (ASJ)
AF:
0.377
AC:
196
AN:
520
East Asian (EAS)
AF:
0.0845
AC:
61
AN:
722
South Asian (SAS)
AF:
0.178
AC:
93
AN:
522
European-Finnish (FIN)
AF:
0.310
AC:
311
AN:
1004
Middle Eastern (MID)
AF:
0.227
AC:
15
AN:
66
European-Non Finnish (NFE)
AF:
0.359
AC:
3691
AN:
10282
Other (OTH)
AF:
0.329
AC:
338
AN:
1026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
165
331
496
662
827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.276
AC:
41935
AN:
152104
Hom.:
6588
Cov.:
32
AF XY:
0.267
AC XY:
19871
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.149
AC:
6201
AN:
41496
American (AMR)
AF:
0.306
AC:
4678
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
1156
AN:
3470
East Asian (EAS)
AF:
0.0951
AC:
492
AN:
5172
South Asian (SAS)
AF:
0.168
AC:
811
AN:
4832
European-Finnish (FIN)
AF:
0.319
AC:
3379
AN:
10580
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.357
AC:
24281
AN:
67948
Other (OTH)
AF:
0.276
AC:
584
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1531
3062
4592
6123
7654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
19758
Bravo
AF:
0.273

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Renal hypomagnesemia 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.9
DANN
Benign
0.52
PhyloP100
0.29
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11999; hg19: chr11-117690918; API